IDENTIFYING PRE-DIABETES IN THE SETTING OF ACUTE CEREBRAL ISCHEMIA

在急性脑缺血的情况下识别糖尿病前期

• 批准号: 7603840
• 负责人: Jennifer Juhl Majersik
• 金额: $ 0.18万
• 依托单位: UNIVERSITY OF MICHIGAN AT ANN ARBOR
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-03-01 至 2007-09-16
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7603840
• 关键词: Acute; Blood; Blood Glucose; Cerebral Ischemia; Computer Retrieval of Information on Scientific Projects Database; Diabetes Mellitus; Diagnosis; Disease; Fasting; Fructosamine; Funding; Glucose; Grant; Hemoglobin concentration result; Institution; Insulin; Metabolism; Patients; Plasma; Predictive Value; Research; Research Personnel; Resources; Risk Factors; Source; Stress; Stroke; United States National Institutes of Health; diabetes risk; response

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Pre-diabetes is a disorder of blood sugar metabolism that places people at risk for diabetes. It has also been shown to be a risk factor for stroke. Patients with recent stroke often have high blood sugars, but we do not know if that means the patient has pre-diabetes or if this is just a response to the stress of a stroke. In this study, we hope to determine what the best way is to diagnose pre-diabetes in patients who have just had a stroke. We will do this by evaluating the predictive value of blood markers of elevated blood sugar, specifically fasting plasma glucose, fasting insulin level, hemoglobin A1C, and fructosamine.'

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 糖尿病前期是一种血糖代谢紊乱，使人们有患糖尿病的风险。它也被证明是中风的危险因素。最近中风的患者通常有高血糖，但我们不知道这是否意味着患者患有糖尿病前期，或者这只是对中风压力的反应。在这项研究中，我们希望确定诊断刚刚中风的患者的糖尿病前期的最佳方法。我们将通过评估血糖升高的血液标志物，特别是空腹血糖，空腹胰岛素水平，血红蛋白A1 C和果糖胺的预测价值来做到这一点。'